レナサイエンスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/04/04 | 1,011 | 1,063 | 963 | 1,023 | -40 | -3.8% | 662,100 |
| 2025/04/03 | 977 | 1,063 | 957 | 1,063 | +53 | +5.2% | 378,100 |
| 2025/04/02 | 1,017 | 1,025 | 993 | 1,010 | -18 | -1.8% | 333,100 |
| 2025/04/01 | 1,040 | 1,053 | 1,003 | 1,028 | -20 | -1.9% | 462,500 |
| 2025/03/31 | 1,045 | 1,099 | 1,024 | 1,048 | -57 | -5.2% | 485,100 |
| 2025/03/28 | 1,125 | 1,164 | 1,086 | 1,105 | -30 | -2.6% | 540,500 |
| 2025/03/27 | 1,120 | 1,170 | 1,100 | 1,135 | -15 | -1.3% | 665,300 |
| 2025/03/26 | 1,105 | 1,230 | 1,079 | 1,150 | +20 | +1.8% | 1,612,700 |
| 2025/03/25 | 1,215 | 1,224 | 1,130 | 1,130 | -72 | -6% | 565,500 |
| 2025/03/24 | 1,248 | 1,248 | 1,180 | 1,202 | -55 | -4.4% | 670,800 |
| 2025/03/21 | 1,240 | 1,291 | 1,229 | 1,257 | +11 | +0.9% | 1,124,400 |
| 2025/03/19 | 1,087 | 1,403 | 1,087 | 1,246 | +130 | +11.6% | 6,861,800 |
| 2025/03/18 | 1,135 | 1,154 | 1,043 | 1,116 | -6 | -0.5% | 1,455,500 |
| 2025/03/17 | 1,002 | 1,122 | 990 | 1,122 | +150 | +15.4% | 744,800 |
| 2025/03/14 | 987 | 1,013 | 967 | 972 | -14 | -1.4% | 326,600 |
| 2025/03/13 | 1,003 | 1,030 | 981 | 986 | -14 | -1.4% | 341,500 |
| 2025/03/12 | 976 | 1,028 | 966 | 1,000 | +49 | +5.2% | 700,400 |
| 2025/03/11 | 983 | 990 | 917 | 951 | -55 | -5.5% | 771,400 |
| 2025/03/10 | 1,040 | 1,063 | 976 | 1,006 | -64 | -6% | 1,077,400 |
| 2025/03/07 | 1,151 | 1,152 | 1,041 | 1,070 | -109 | -9.2% | 879,900 |
| 2025/03/06 | 1,305 | 1,310 | 1,170 | 1,179 | -135 | -10.3% | 1,295,100 |
| 2025/03/05 | 1,206 | 1,327 | 1,187 | 1,314 | +83 | +6.7% | 926,000 |
| 2025/03/04 | 1,314 | 1,336 | 1,210 | 1,231 | -107 | -8% | 611,600 |
| 2025/03/03 | 1,247 | 1,370 | 1,215 | 1,338 | +102 | +8.3% | 614,500 |
| 2025/02/28 | 1,370 | 1,370 | 1,212 | 1,236 | -144 | -10.4% | 775,700 |
| 2025/02/27 | 1,451 | 1,460 | 1,345 | 1,380 | -119 | -7.9% | 995,000 |
| 2025/02/26 | 1,456 | 1,519 | 1,420 | 1,499 | +56 | +3.9% | 1,088,500 |
| 2025/02/25 | 1,323 | 1,450 | 1,321 | 1,443 | +116 | +8.7% | 905,900 |
| 2025/02/21 | 1,322 | 1,390 | 1,286 | 1,327 | +4 | +0.3% | 628,500 |
| 2025/02/20 | 1,334 | 1,358 | 1,286 | 1,323 | -1 | -0.1% | 540,400 |
| 2025/02/19 | 1,407 | 1,473 | 1,297 | 1,324 | -83 | -5.9% | 1,210,100 |
| 2025/02/18 | 1,427 | 1,579 | 1,375 | 1,407 | -21 | -1.5% | 2,065,800 |
| 2025/02/17 | 1,565 | 1,758 | 1,372 | 1,428 | -97 | -6.4% | 3,996,000 |
| 2025/02/14 | 1,299 | 1,525 | 1,291 | 1,525 | +300 | +24.5% | 2,191,900 |
| 2025/02/13 | 1,316 | 1,316 | 1,170 | 1,225 | -72 | -5.6% | 730,200 |
| 2025/02/12 | 1,187 | 1,390 | 1,165 | 1,297 | +99 | +8.3% | 1,918,000 |
| 2025/02/10 | 1,155 | 1,247 | 1,144 | 1,198 | -15 | -1.2% | 944,200 |
| 2025/02/07 | 1,200 | 1,310 | 1,150 | 1,213 | -36 | -2.9% | 1,305,200 |
| 2025/02/06 | 1,199 | 1,399 | 1,173 | 1,249 | +49 | +4.1% | 2,204,800 |
| 2025/02/05 | 1,391 | 1,393 | 1,180 | 1,200 | -177 | -12.9% | 1,650,500 |
| 2025/02/04 | 1,585 | 1,667 | 1,206 | 1,377 | -48 | -3.4% | 4,732,100 |
| 2025/02/03 | 1,080 | 1,425 | 1,056 | 1,425 | +300 | +26.7% | 6,346,900 |
| 2025/01/31 | 1,185 | 1,500 | 1,125 | 1,125 | -400 | -26.2% | 5,619,200 |
| 2025/01/30 | 2,375 | 2,474 | 1,525 | 1,525 | -500 | -24.7% | 2,092,900 |
| 2025/01/29 | 1,705 | 2,025 | 1,650 | 2,025 | +400 | +24.6% | 5,385,900 |
| 2025/01/28 | 1,355 | 1,625 | 1,355 | 1,625 | +300 | +22.6% | 5,434,100 |
| 2025/01/27 | 1,160 | 1,340 | 1,142 | 1,325 | +285 | +27.4% | 7,793,200 |
| 2025/01/24 | 944 | 1,040 | 935 | 1,040 | +150 | +16.9% | 2,316,100 |
| 2025/01/23 | 944 | 1,004 | 865 | 890 | +36 | +4.2% | 7,138,600 |
| 2025/01/22 | 726 | 854 | 705 | 854 | +150 | +21.3% | 3,961,700 |
1～
50
件表示中 / 864件
類似銘柄と比較する
現在ご覧いただいている「レナサイエンス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| レナサイエンス | 102,300円 | -34.5% | - | 0.00% | 282.60倍 | 8.48倍 |
|
東北大発創薬ベンチャー。創業者の宮田同大教授が発見した低分子化合物を使い治療薬を開発 |
| Ｃｈｏｒｄｉａ | 24,500円 | - | - | 0.00% | - | 4.07倍 |
|
ＲＮＡ制御ストレスを標的とする低分子抗がん薬を開発中。開発品・研究者は武田にルーツ |
| オンコリス | 53,200円 | +3771.0% | - | 0.00% | - | 4.82倍 |
|
腫瘍溶解ウイルス技術使うがん治療薬柱に感染症薬も開発。導出先が神経疾患薬を米国治験中 |
| 大幸薬品 | 25,600円 | +0.1% | -70.9% | 0.00% | 42.81倍 | 1.61倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。感染管理「クレベリン」事業は再構築中 |
| セルソース | 64,400円 | - | - | 0.78% | 50.04倍 | 2.13倍 |
|
脂肪・血液由来の細胞加工受託など再生医療、変形性ひざ関節症向け軸に不妊治療関連も展開 |
市場注目の銘柄
チャート関連のコラム
